SEC FORM
3
SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0104 |
Estimated average burden |
hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
C/O MORAL COMPASS CORPORATION |
4835 E. EXETER BLVD. |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 05/14/2015
|
3. Issuer Name and Ticker or Trading Symbol
Arcadia Biosciences, Inc.
[ RKDA ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Beneficially Owned |
1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Common Stock |
160,714 |
I |
By Moral Compass Corporation
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Series A Convertible Preferred Stock |
|
|
Common Stock |
60,681,805 |
|
I |
By Moral Compass Corporation
|
Series B Convertible Preferred Stock |
|
|
Common Stock |
15,391,006 |
|
I |
By Moral Compass Corporation
|
Series C Convertible Preferred Stock |
|
|
Common Stock |
9,345,794 |
|
I |
By Moral Compass Corporation
|
1. Name and Address of Reporting Person*
C/O MORAL COMPASS CORPORATION |
4835 E. EXETER BLVD. |
(Street)
|
1. Name and Address of Reporting Person*
C/O MORAL COMPASS CORPORATION |
4835 E. EXETER BLVD. |
(Street)
|
1. Name and Address of Reporting Person*
(Street)
|
1. Name and Address of Reporting Person*
(Street)
|
1. Name and Address of Reporting Person*
(Street)
|
1. Name and Address of Reporting Person*
(Street)
|
Explanation of Responses: |
Remarks: |
|
/s/ Jeffrey Hamilton, as Attorney-in-Fact for Terri Bishop |
05/14/2015 |
|
Jeffrey Hamilton, as Attorney-in-Fact for Peter Sperling |
05/14/2015 |
|
Jeffrey Hamilton, as Attorney-in-Fact for Moral Compass Corporation |
05/14/2015 |
|
Jeffrey Hamilton, as Attorney-in-Fact for John G. Sperling 2012 Irrevocable Trust No. 1 |
05/14/2015 |
|
Jeffrey Hamilton, as Attorney-in-Fact for John G. Sperling 2012 Irrevocable Trust No. 2 |
05/14/2015 |
|
Jeffrey Hamilton, as Attorney-in-Fact for John G. Sperling 2012 Irrevocable Trust No. 3 |
05/14/2015 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS that the undersigned hereby constitute and appoint
each of Philip Peters and Jeffrey Hamilton of Farella Braun + Martel, LLP (any
of whom may act individually), the undersigned's true and lawful
attorney-in-fact and agents to:
1. Complete and execute Forms 3, 4 and 5 and other forms and all
amendments thereto as such attorney-in-fact shall in his discretion
determine to be required or advisable pursuant to Section 16 of the
Securities Exchange Act of 1934 (as amended) (the "Exchange Act") and
the rules and regulations promulgated thereunder, or any successor
laws and regulations, as a consequence of the undersigned's ownership,
acquisition or disposition of securities of Arcadia Biosciences, Inc.
(the "Company");
2. Do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to prepare, complete and execute
any such Form 3, 4 or 5 (including amendments thereto and joint filing
agreements in connection therewith) and timely file such forms with
the Securities and Exchange Commission (the "SEC") and any stock
exchange, self-regulatory association or any other authority; and
3. Take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of any such attorney-in-fact, may be
necessary or desirable in connection with the foregoing authority, it
being understood that the documents executed by any such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as the attorney-in-fact may approve in the
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and
their substitutes, in serving in such capacity at the request of the
undersigned, are not assuming (nor is the Company assuming) any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to any
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the Company and the attorneys-in-fact or, as to any
attorney-in-fact individually, if such attorney-in-fact is no longer employed by
Farella Braun + Martel LLP. This Power of Attorney may be filed with the SEC as
a confirming statement of the authority granted herein.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 14th day of May, 2015.
MORAL COMPASS CORPORATION
By: /s/ Darby Shupp
------------------------------
Name: Darby Shupp
Title: Secretary
JOHN G. SPERLING 2012 IRREVOCABLE TRUST NO. 1
By: /s/ Darby Shupp
------------------------------
Name: Darby Shupp
Title: Trustee
By: /s/ Terri Bishop
------------------------------
Name: Terri Bishop
Title: Trustee
JOHN G. SPERLING 2012 IRREVOCABLE TRUST NO. 2
By: /s/ Darby Shupp
------------------------------
Name: Darby Shupp
Title: Trustee
By: /s/ Terri Bishop
------------------------------
Name: Terri Bishop
Title: Trustee
JOHN G. SPERLING 2012 IRREVOCABLE TRUST NO. 3
By: /s/ Darby Shupp
-----------------------------
Name: Darby Shupp
Title: Trustee
By: /s/ Terri Bishop
------------------------------
Name: Terri Bishop
Title: Trustee
By: /s/ Terri Bishop
------------------------------
Name: Terri Bishop
By: /s/ Peter Sperling
------------------------------
Name: Peter Sperling